ArticleCancer reports (Hoboken, N.J.)2025

Efficacy and Safety of Combination Androgen-Receptor Signaling Inhibitors, Denosumab, and Local Radiotherapy for Poly-Metastatic Prostate Cancer.

Makoto Kawase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.